2,790
Views
1
CrossRef citations to date
0
Altmetric
Research Article

COPD Assessment Test as a Screening Tool for Anxiety and Depression in Stable COPD Patients: A Feasibility Study

ORCID Icon, , , , , , & show all
Pages 144-152 | Received 26 Sep 2022, Accepted 18 Jan 2023, Published online: 10 Apr 2023

References

  • López-Campos JL, Tan W, Soriano JB. Global burden of COPD. Respirology. 2016;21(1):14–23. DOI:10.1111/resp.12660
  • Negewo NA, Gibson PG, McDonald VM. COPD and its comorbidities: impact, measurement and mechanisms. Respirology. 2015;20(8):1160–1171. DOI:10.1111/resp.12642
  • Pumar MI, Gray CR, Walsh JR, et al. Anxiety and depression-Important psychological comorbidities of COPD. J Thorac Dis. 2014;6(11):1615–1631. DOI:10.3978/j.issn.2072-1439.2014.09.28
  • Xu W, Collet JP, Shapiro S, et al. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit Care Med. 2008;178(9):913–920. DOI:10.1164/rccm.200804-619OC
  • Pooler A, Beech R. Examining the relationship between anxiety and depression and exacerbations of COPD which result in hospital admission: a systematic review. Int J Chron Obstruct Pulmon Dis. 2014;9:315–330. DOI:10.2147/COPD.S53255
  • Gudmundsson G, Gislason T, Janson C, et al. Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J. 2005;26(3):414–419. DOI:10.1183/09031936.05.00078504
  • Eisner MD, Blanc PD, Yelin EH, et al. Influence of anxiety on health outcomes in COPD. Thorax. 2010;65(3):229–234. DOI:10.1136/thx.2009.126201
  • Abrams TE, Vaughan-Sarrazin M, Van der Weg MW. Acute exacerbations of chronic obstructive pulmonary disease and the effect of existing psychiatric comorbidity on subsequent mortality. Psychosomatics. 2011;52(5):441–449. DOI:10.1016/j.psym.2011.03.005
  • Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–370. DOI:10.1111/j.1600-0447.1983.tb09716.x
  • Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50–55. DOI:10.1111/j.2044-8341.1959.tb00467.x
  • Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56–62. DOI:10.1136/jnnp.23.1.56
  • Beck AT, Epstein N, Brown G, et al. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56(6):893–897. DOI:10.1037//0022-006x.56.6.893
  • Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–571. DOI:10.1001/archpsyc.1961.01710120031004
  • Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648–654. DOI:10.1183/09031936.00102509
  • Jones P, Harding G, Wiklund I, et al. Improving the process and outcome of care in COPD: development of a standardised assessment tool. Prim Care Respir J. 2009;18(3):208–215. DOI:10.4104/pcrj.2009.00053
  • Houben-Wilke S, Janssen DJA, Franssen FME, et al. Contribution of individual COPD assessment test (CAT) items to CAT total score and effects of pulmonary rehabilitation on CAT scores. Health Qual Life Out. 2018;16(1):205. DOI:10.1186/s12955-018-1034-4
  • Harryanto H, Burrows S, Moodley Y. A high COPD assessment test score may predict anxiety in COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:955–957. DOI:10.2147/COPD.S152950
  • Hilmarsen CW, Wilke S, Engan H, et al. Impact of symptoms of anxiety and depression on COPD assessment test scores. Eur Respir J. 2014;43(3):898–900. DOI:10.1183/09031936.00163913
  • Lim JU, Park CK, Kim TH, et al. The difficulty of improving quality of life in COPD patients with depression and associated factors. Int J Chron Obstruct Pulmon Dis. 2019;14:2331–2341. DOI:10.2147/COPD.S216746
  • Yao HM, Xiao RS, Cao PL, et al. Risk factors for depression in patients with chronic obstructive pulmonary disease. World J Psychiatry. 2020;10(4):59–70. DOI:10.5498/wjp.v10.i4.59
  • Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis management and prevention of COPD 2022. report). [cited 2022 Sept 12]. Available from: https://goldcopd.org/2022-gold-reports-2/.
  • Jian W, Gao Y, Hao C, et al. Reference values for spirometry in chinese aged 4-80 years. J Thorac Dis. 2017;9(11):4538–4549. DOI:10.21037/jtd.2017.10.110
  • Standardization of spirometry, 1994 update American Thoracic society. Am J Respir Crit Care Med. 1995;152(3):1107–1136. DOI:10.1164/ajrccm.152.3.7663792
  • Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest. 1988;93(3):580–586. DOI:10.1378/chest.93.3.580
  • Löwe B, Decker O, Müller S, et al. Validation and standardization of the generalized anxiety disorder screener (GAD-7) in the general population. Med Care. 2008;46(3):266–274. DOI:10.1097/MLR.0b013e318160d093
  • Spitzer RL, Kroenke K, Williams JB, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–1097. DOI:10.1001/archinte.166.10.1092
  • He X, Li C, Qian J, et al. Reliability and validity of a generalized anxiety disorder scale in general hospital outpatient. Shanghai Arch Psych. 2010;22(4):200–203. DOI:10.3969/j.issn.1002-0829.2010.04.002
  • Baker AM, Holbrook JT, Yohannes AM, American Lung Association Airways Clinical Research Centers, et al. Test performance characteristics of the AIR, GAD-7, and HADS-anxiety screening questionnaires for anxiety in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2018;15(8):926–934. DOI:10.1513/AnnalsATS.201708-631OC
  • Wild B, Eckl A, Herzog W, et al. Assessing generalized anxiety disorder in elderly people using the GAD-7 and GAD-2 scales: results of a validation study. Am J Geriatr Psychiatry. 2014;22(10):1029–1038. DOI:10.1016/j.jagp.2013.01.076
  • Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613. DOI:10.1046/j.1525-1497.2001.016009606.x
  • Sun XY, Li YX, Yu CQ, et al. Reliability and validity of depression scales of chinese version: a systematic review. Zhonghua Liu Xing Bing Xue Za Zhi. 2017;38(1):110–116. DOI:10.3760/cma.j.issn.0254-6450.2017.01.021
  • Lee JH, Park MA, Park MJ, et al. Clinical characteristics and related risk factors of depression in patients with early COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:1583–1590. DOI:10.2147/COPD.S157165
  • Guidelines for the diagnosis and management of chronic obstructive pulmonary disease (revised version 2021). Zhonghua jie he he hu xi za Zhi. 2021;44(3):170–205. DOI:10.3760/cma.j.cn112147-20210109-00031
  • Soler-Cataluña JJ, Alcázar-Navarrete B, Miravitlles M. The concept of control of COPD in clinical practice. Int J Chron Obstruct Pulmon Dis. 2014;9:1397–1405. DOI:10.2147/COPD.S71370
  • DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837–845. PMID: 3203132
  • Willgoss TG, Yohannes AM. Anxiety disorders in patients with COPD: a systematic review. Respir Care. 2013;58(5):858–866. DOI:10.4187/respcare.01862
  • Whelan ME, Velardo C, Rutter H, et al. Mood monitoring over one year for people with chronic obstructive pulmonary disease using a mobile health system: retrospective analysis of a randomized controlled trial. JMIR mHealth and uHealth. 2019;7(11):e 14946. DOI:10.2196/14946
  • Yohannes AM, Kaplan A, Hanania NA. Anxiety and depression in chronic obstructive pulmonary disease: recognition and management. Cleve Clin J Med. 2018;85(2 Suppl 1):S11–S18. DOI:10.3949/ccjm.85.s1.03
  • Lou P, Zhu Y, Chen P, et al. Prevalence and correlations with depression, anxiety, and other features in outpatients with chronic obstructive pulmonary disease in China: a cross-sectional case control study. BMC Pulm Med. 2012;12:53. DOI:10.1186/1471-2466-12-53
  • Liu Y, Tian X, Guo X, et al. Prevalence of anxiety and depression in chronic obstructive pulmonary disease. Chin J Respir Crit Care Med. 2020;19(5):425–429. DOI:10.7507/1671-6205.202001049
  • World Health Organization. Depression and other common mental disorders: global health estimates. Geneva, Switzerland: World Health Organization; 2017.
  • Laurin C, Lavoie KL, Bacon SL, et al. Sex differences in the prevalence of psychiatric disorders and psychological distress in patients with COPD. Chest. 2007;132(1):148–155. DOI:10.1378/chest.07-0134
  • Tse HN, Tseng CZ, Wong KY, et al. Frequent Exacerbator: the phenotype at risk of depressive symptoms in geriatric COPD patients. Lung. 2016;194(4):665–673. DOI:10.1007/s00408-016-9887-y
  • Quint JK, Baghai-Ravary R, Donaldson GC, et al. Relationship between depression and exacerbations in COPD. Eur Respir J. 2008;32(1):53–60. DOI:10.1183/09031936.00120107
  • Hanania NA, Mullerova H, Locantore NW, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) study investigators, et al. Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med. 2011;183(5):604–611. DOI:10.1164/rccm.201003-0472OC
  • Gudmundsson G, Gislason T, Janson C, et al. Depression, anxiety and health status after hospitalisation for COPD: a multicentre study in the nordic countries. Respir Med. 2006;100(1):87–93. DOI:10.1016/j.rmed.2005.04.003
  • Wagena EJ, Arrindell WA, Wouters EF, et al. Are patients with COPD psychologically distressed? Eur Respir J. 2005;26(2):242–248. DOI:10.1183/09031936.05.00010604
  • Hayashi Y, Senjyu H, Iguchi A, et al. Prevalence of depressive symptoms in japanese male patients with chronic obstructive pulmonary disease. Psychiatry Clin Neurosci. 2011;65(1):82–88. DOI:10.1111/j.1440-1819.2010.02171.x
  • Guillien A, Laurent L, Soumagne T, et al. Anxiety and depression among dairy farmers: the impact of COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:1–9. DOI:10.2147/COPD.S143883
  • Funk GC, Kirchheiner K, Burghuber OC, et al. BODE index versus GOLD classification for explaining anxious and depressive symptoms in patients with COPD - a cross-sectional study. Respir Res. 2009;10(1):1. DOI:10.1186/1465-9921-10-1
  • Huang K, Huang K, Xu J, et al. Anxiety and depression in patients with chronic obstructive pulmonary disease in China: results from the China pulmonary health [CPH] study. Int J Chron Obstruct Pulmon Dis. 2021;16:3387–3396. DOI:10.2147/COPD.S328617
  • Tetikkurt C, Ozdemir I, Tetikkurt S, et al. Anxiety and depression in COPD patients and correlation with sputum and BAL cytology. Multidiscip Respir Med. 2011;6(4):226–231. DOI:10.1186/2049-6958-6-4-226
  • Doyle T, Palmer S, Johnson J, et al. Association of anxiety and depression with pulmonary-specific symptoms in chronic obstructive pulmonary disease. Int J Psychiatry Med. 2013;45(2):189–202. DOI:10.2190/PM.45.2.g
  • Lee YS, Park S, Oh YM, Korean COPD Study Group, et al. Chronic obstructive pulmonary disease assessment test can predict depression: a prospective multi-center study. J Korean Med Sci. 2013;28(7):1048–1054. DOI:10.3346/jkms.2013.28.7.1048
  • Lamers F, Jonkers CC, Bosma H, et al. Summed score of the patient health questionnaire-9 was a reliable and valid method for depression screening in chronically ill elderly patients. J Clin Epidemiol. 2008;61(7):679–687. DOI:10.1016/j.jclinepi.2007.07.018